Information Provided By:
Fly News Breaks for March 17, 2015
ESPR
Mar 17, 2015 | 12:14 EDT
Credit Suisse raised its price target on Esperion to $130 from $100 citing the company's phase 2b study of ETC-1002, which met its primary endpoints. The firm has an Outperform rating on the shares.
News For ESPR From the Last 2 Days
ESPR
Mar 28, 2024 | 10:59 EDT
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Altamira Therapeutics... To see the rest of the story go to thefly.com. See Story Here
ESPR
Mar 27, 2024 | 10:47 EDT
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Altamira Therapeutics... To see the rest of the story go to thefly.com. See Story Here